Carlsbad, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) — Aurora Backbone Company (“Aurora Backbone” or the “Firm”) (TSXV:ASG) (OTCQB: ASAPF), a designer and producer of modern medical gadgets that enhance spinal surgical procedure outcomes, introduced as we speak that it’s in full business launch of its proprietary SiLO TFX™ MIS Sacroiliac Joint Fixation Machine system.
The patented, minimally invasive SiLO TFX MIS Sacroiliac Joint Fixation System is meant for sacroiliac joint fusion for situations together with sacroiliac joint disruptions and degenerative sacroiliitis. The SiLO TFX MIS Sacroiliac Joint Fixation System features a Transfixing-Cone, an ilium screw, a sacrum screw and related instrumentation. The SiLO TFX implants are designed to transfix the sacrum and ilium, offering stability for bony fusion.
Mr. Trent Northcutt, Aurora’s President, CEO and co-founder, said, “We’re excited to be in full launch of our recreation altering remedy for sufferers struggling with SI Joint ache and disfunction.”
Petra Lopizzo, Aurora’s Director of Operations, mentioned “The discharge of SiLO TFX is continuing easily and quickly as we deploy extra devices units and implants into the sphere. I’m happy with the teamwork between Engineering, Operations and Advertising on the complete launch of the SiLO TFX system.”
About Aurora Backbone
Aurora Backbone is targeted on bringing new options to the spinal implant market by a collection of modern, minimally invasive, regenerative spinal implant applied sciences. Further data could be accessed at www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Enterprise Alternate nor its Regulation Companies Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Alternate) accepts accountability for the adequacy or accuracy of this launch.
This information launch incorporates forward-looking data that entails substantial recognized and unknown dangers and uncertainties, most of that are past the management of Aurora Backbone, together with, with out limitation, these listed underneath “Threat Components” and “Cautionary Assertion Concerning Ahead-Wanting Data” in Aurora Backbone’s closing prospectus (collectively, “forward-looking data”). Ahead-looking data on this information launch contains data regarding the proposed use and success of the corporate’s merchandise in surgical procedures. Aurora Backbone cautions traders of Aurora Backbone’s securities about necessary elements that would trigger Aurora Backbone’s precise outcomes to vary materially from these projected in any forward-looking statements included on this information launch. Any statements that specific, or contain discussions as to, expectations, beliefs, plans, targets, assumptions or future occasions or efficiency are usually not historic details and could also be forward-looking and will contain estimates, assumptions and uncertainties which might trigger precise outcomes or outcomes to vary unilaterally from these expressed in such forward-looking statements. No assurance could be provided that the expectations set out herein will show to be appropriate and, accordingly, potential traders shouldn’t place undue reliance on these forward-looking statements. These statements converse solely as of the date of this press launch and Aurora Backbone doesn’t assume any obligation to replace or revise them to replicate new occasions or circumstances.
Aurora Backbone Company
President and Chief Government Officer
Chief Monetary Officer
LYTHAM PARTNERS, LLC
Phoenix | New York